Gault Laura bought SAGE
February 13, 2024 · Form 4 insider transaction
Gault Laura bought 11,250 shares of SAGE Therapeutics Holdings at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,250
Price
$0.00
Total value
N/A
InsiderGault Laura
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 13, 2024
Filing dateFebruary 15, 2024
Shares owned after11,477
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Consists of shares of common stock issuable under 11,250 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on February 13, 2025.; Reflects beneficial ownership balance which includes 227 shares purchased on December 29,2023 under the Sage Therapeutics, Inc. 2014 Employee Stock Purchase Plan.